Shares of Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of C$7.32 and traded as low as C$7.10. Eupraxia Pharmaceuticals shares last traded at C$7.25, with a volume of 1,015,479 shares trading hands.
Eupraxia Pharmaceuticals Price Performance
The company has a 50-day moving average price of C$7.54 and a 200-day moving average price of C$7.32.
Eupraxia Pharmaceuticals Company Profile
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing locally administered therapies for inflammatory and fibrotic diseases. The company’s programs are designed to deliver active pharmaceutical ingredients directly to affected tissues while potentially limiting systemic exposure and associated side effects.
Eupraxia’s development platform uses a proprietary diffusion-based hydrogel technology intended to provide controlled, sustained drug release.
Featured Articles
- Five stocks we like better than Eupraxia Pharmaceuticals
- Amazon’s Record Margins Couldn’t Stop the Sell-Off—Here’s Why
- DoorDash’s $17 Billion Bet on Instacart Faces a Long Regulatory Road Ahead
- FTC Puts A Wrinkle In the Cintas and UniFirst Merger
- Breaching the Valuation: The Real Reason Fortinet Dropped
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
